Impax Laboratories Inc.
31.42-0.05 (-0.16%)

After hours: 31.41-0.01 (-0.02%) as of 4:46 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close31.47
Bid30.81 x 100
Ask0.00 x
52wk Range27.62 - 49.59
Day's Range30.63 - 31.51
Avg Vol (3m)657,457
As of 4:00 PM EDT. Market closed.
  • Reuters2 days ago

    Teva, Allergan win U.S. antitrust approval for generics deal

    Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The $40.5 billion deal, which was announced in July 2015, solidifies Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs. Teva will sell rights and assets related to the 79 pharmaceutical products to 11 rival firms, marking the largest ever drug divestiture order in an FTC pharmaceutical merger case, the commission said in a statement.

  • Zacks8 days ago

    4 Low P/CF Stocks to Improve Your Value Investing

    Value style is generally considered one of the best practices when it comes to picking stocks.